From £7.99 per month
ShareProphets
The one stop source for breaking news, expert analysis, and podcasts on fast-moving AIM and LSE listed shares

MINDING THE LSE’S BUSINESS

Join for as low as £7.99 per month

With ShareProphets’ membership, you receive:

• All premium articles

• Tom Winnifrith’s Bearcast

• Access to all the entire nearly 10 year archive

• ShareProphets Daily Newsletter

Tom Winnifrith Bearcast: Is there something Manolete wants to tell us all?

By Tom Winnifrith | Monday 14 September 2020


Disclosure: I own shares in one or more of the stocks mentioned. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from ShareProphets). I have no business relationship with any company whose stock is mentioned in this article.


It was on July 10 that we published an explosive dossier on Manolete (MANO ) warning that its shares would fall by 66%. It responded with a wankerish statement insulting ShareProphets and which was full of waffle. Its shares are tanking today and are now down 40%+ since our report. is there anything it wishes to say? Elsewhere, I look at Symphony Environmental (SYM) and Covid madness, at Brighton Pier (PIER) and the maths of the hospitality industry, and finally take on Gary Newman on Red Rock Resources (RRR) suggesting he is blinded by #BellDerangementSyndrome and so cannot look at facts. What would Red Rock trade at if it had a different boss I wonder?

You must be a paid subscriber to listen to Bearcast
ShareProphets is reader-supported journalism

Join us for free and gain access to three articles per month

Or become a member starting at £6.99 per month for all articles, the Bearcast, and our seven year archive.


Filed under:



Subscribe to our newsletter

Daily digest of our latest stories.



Search ShareProphets

Market News

Complete Coverage

Recent Comments

That Was the Week that Was

Saturday »

AVCT

Cassava, A warning to Avacta Sharehoders 

Friday »

ALU

Alumasc Group – a growth Buy

 

VCP

Victoria - The roll up unravels

 

HEMO

Hemogenyx is a short – target 0p

 

ECR

ECR, the timing is unfortunate

 

APH

Alliance Pharma – a recovery Buy?

Time left: 19:21:44